Bloomberg News

Feb 6 2023

(STUDY) Merck’s Covid pill linked to creation of new Covid mutations

By Sharyl Attkisson / February 6, 2023

The following is an excerpt from Bloomberg News. Merck & Co.’s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s […]

(STUDY) Merck’s Covid pill linked to creation of new Covid mutations Read More »

May 8 2022

Pfizer’s Paxlovid Covid-19 drug studied after reports of ‘relapses’

By Sharyl Attkisson / May 8, 2022

The following is an excerpt from WebMD. U.S. researchers are planning to study how often and why coronavirus levels come back for some Covid-19 patients who take Pfizer’s Paxlovid drug, according to Bloomberg News. “It is a priority,” Clifford Lane, MD,

Pfizer’s Paxlovid Covid-19 drug studied after reports of ‘relapses’ Read More »

(STUDY) Merck’s Covid pill linked to creation of new Covid mutations

Pfizer’s Paxlovid Covid-19 drug studied after reports of ‘relapses’

Keep Independent Journalism Alive

Subscribe To The Newspresso Daily